Can-Fite BioPharma Ltd. (TLV:CANF)
Israel
· Delayed Price · Currency is ILS · Price in ILA 2.000
+0.100 (5.26%)
Feb 20, 2025, 5:24 PM IDT
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of 60.12 million as of February 21, 2025. Its market cap has increased by 88.79% in one year.
Market Cap
60.12M
Enterprise Value
42.54M
Revenue
2.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.00
Market Cap Chart
Since June 12, 2006, Can-Fite BioPharma's market cap has increased from 16.04M to 60.12M, an increase of 274.86%. That is a compound annual growth rate of 7.32%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 68.37B |
| Danel (Adir Yeoshua) | 2.53B |
| Kamada | 1.57B |
| Bait Bakfar | 1.09B |
| Novolog (Pharm-Up 1966) | 907.03M |
| Ilex Medical | 800.59M |
| BrainsWay | 762.81M |
| SofWave Medical | 597.96M |